Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.51
-0.05 (-0.66%)
At close: Aug 29, 2025, 4:00 PM
7.37
-0.14 (-1.86%)
After-hours: Aug 29, 2025, 6:15 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $244.24 million as of August 29, 2025. Its market cap has increased by 209.84% in one year.
Market Cap
244.24M
Enterprise Value
108.92M
1-Year Change
209.84%
Ranking
Category
Stock Price
$7.51
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $244.24M, a decrease of -31.16%. That is a compound annual growth rate of -16.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 244.24M | 68.58% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 654.44B |
| Johnson & Johnson | 422.95B |
| AbbVie | 365.52B |
| UnitedHealth Group | 274.42B |
| Novo Nordisk | 249.15B |
| AstraZeneca | 247.25B |
| Novartis AG | 245.07B |
| Abbott Laboratories | 227.50B |